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889-Symp
Conformational Changes in Voltage-Sensing Domains: Concerted Simula-
tion and Scattering Studies
Douglas J. Tobias.
Chemistry, University California, Irvine, Irvine, CA, USA.
Electrical signals in excitable tissues such as nerves and muscles are generated
by the synchronized opening and closing of ion channels in cell membranes,
which generate transient transmembrane gradients in the concentrations of
sodium and potassium ions. These channels open and close in response to local
changes in transmembrane potential as the signal propagates, and it is well
established that their voltage sensitivity is conferred by charged structural ele-
ments, referred to as voltage-sensing domains. The details of how conforma-
tional changes in the voltage-sensing domains lead to opening/closing of the
ion-conducting pores of the channels are still being worked out. Crystal struc-
tures of the open states of voltage-gated potassium channels are available, but
the structure of the closed/resting state has not been determined to high resolu-
tion experimentally. In this talk I will report our efforts to generate a model of
the resting state of the archaeal KvAP potassium channel based on atomistic
molecular dynamics (MD) simulations in explicit membrane environments,
with restraints derived from experimental functional data. I will also present re-
sults from simulation studies of an isolated voltage-sensing domain in a hydrat-
ed membrane, which include validation by neutron diffraction measurements,
and direct observations of elementary gating charge displacement events during
a 30-microsecond MD simulation under applied transmembrane potential.
Finally, I will discuss prospects for and present preliminary results on using
x-ray and neutron interferometry measurements, carried out by our collabora-
tors, to validate and refine simulation-based models of the resting state and the
voltage-sensing mechanism.
890-Symp
Tricking Out the Toolbox: Use of Genetic Code Expansion for the Study of
Ion Channels
Chris Ahern.
Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA,
USA.
The application of nonsense suppression strategies to membrane proteins has
great potential for the study and manipulation of ion channels and receptors.
The technique relies on the incorporation of a stop codon that is subsequently
‘suppressed’ by an orthogonal misacylated tRNA. Ion channels in particular are
especially amenable to these approaches due to the built-in signal gain from the
high conductance of recorded ions. On one end of the scale of possibility,
‘small mutagenesis’ provides the means for single atom replacement within
an amino acid or sub-atomic redistribution of pi electrons of aromatic side-
chains. Such approaches provide an atomic resolution functional correlates to
match high-resolution structural data, and have been key in decoding the inter-
action energetics of ligands, therapeutics, backbone contributions, salt-bridges
and H-bonds in gating of voltage- and ligand-gated channels and receptors.
More unconventional side-chains, such as light activated cross-linkers, hold
promise for their ability to characterize transient noncovalent protein contacts.
Lastly, encoded amino acid fluorophores, while highly valued, have been tech-
nically resistant to ion channel application and largely remain on the experi-
mental fringe. Data will be presented on the use of genetic code expansion
as a tool to reveal the basis for inactivation mechanisms employed by
voltage-gated sodium and potassium channels.
891-Symp
Small Molecule Modulation of Voltage-Gated Ion Channels
Heike Wulff1, Vladimir Yarov-Yarovoy2.
1Pharmacology, University of California, Davis, Davis, CA, USA,
2Physiology and Membrane Biology, University of California, Davis, Davis,
CA, USA.
Pharmacological modulation of voltage-gated-like ion channels offers tremen-
dous opportunities for the discovery of new drugs for neurological, cardiovas-
cular and metabolic disorders, as well as for immunosuppression and cancer.
However, in contrast to other therapeutic targets such as protein kinases,
voltage-gated ion channels have not been popular with medicinal chemists in
the pharmaceutical industry. One reason for this unpopularity is the absence
of co-crystals of medically relevant channels with drug molecules bound, a pre-
requisite for structure based drug design. To address this challenge, molecular
modeling, which recently made significant advances due to improved compu-
tational methods, and the availability of more high-resolution ion channel struc-
tures, is increasingly being used to interpret the results of mutational andelectrophysiological experiments in structural terms. Using the Kv1.3 blocker
PAP-1 and several KCa2/3 channel modulators such as TRAM-34, NS8593,
and nifedipine as examples we here demonstrate that small molecule drugs
can ‘‘snuggle’’ into every available nook and cranny of voltage-gated ion chan-
nels: the central cavity, the side-pockets between the pore-domain and voltage-
sensor, the S5-S6 interface or the lateral fenestrations. We will further discuss
the recent design of the KCa3.1 selective positive gating modulator SKA-121
(5-methylnaphtho[2,1-d]oxazol-2-amine), a compound that binds at the inter-
face of the calmodulin N-lobe and the calmodulin binding domain of
KCa3.1. Overall these examples illustrate that voltage-gated ion channels are
highly accessible to small molecule drugs and that virtually any domain of
these large, multi-subunit proteins can be targeted for the design of channel
subtype-specific drugs, a major challenge remaining in the ion channel field.
Supported by RO1 GM076063 (to H.W.) and UC Davis startup (to V.Y.).
892-Symp
Calcium Channel Engineering
Henry M. Colecraft.
Physiology and Cellular Biophysics, Columbia University, New York,
NY, USA.
High-voltage-activated calcium (CaV) channels convert electrical signals into
Ca2þ ion influx to trigger biological responses in excitable cells. CaV channel
dysfunction underlies many cardiovascular and neurological diseases, from
cardiac arrhythmias to autism. Modulation of CaV channels by intracellular
signaling proteins, Ca2þ ions and various small molecules is a powerful method
to regulate physiology and is therapeutic for myriad disease conditions. I will
discuss CaV channel engineering approaches that we have used to gain insights
into the structure-function mechanisms of these vital proteins, to probe their
physiological roles, and to develop novel genetically-encoded molecules that
modulate their activity.Platform: Calcium Signaling
893-Plat
Decreased Polycystin 2 Expression Alters Calcium-Contraction Coupling
and Changes Beta-Adrenergic Signaling Pathways
Ivana Y. Kuo1, Andrea T. Kwaczala2, Lily Nguyen3, Stuart G. Campbell2,
Barbara E. Ehrlich1.
1Pharmacology, Yale University, New Haven, CT, USA, 2Biomedical
Engineering, Yale University, New Haven, CT, USA, 3Cardiology, Yale
University, New Haven, CT, USA.
Cardiac disorders are the main cause of mortality in autosomal dominant poly-
cystic kidney disease (ADPKD). However, how mutated polycystins predis-
pose ADPKD patients to cardiac pathologies before development of renal
dysfunction is unknown. We investigate the effect of decreased polycystin 2
(PC2) levels, a calcium channel that interacts with the ryanodine receptor, on
myocardial function. We hypothesize that heterozygous PC2 mice (Pkd2þ/)
undergo cardiac remodeling due to changes in calcium handling, separate to
renal complications. We found that Pkd2þ/ cardiomyocytes have altered cal-
cium handling, independent of desensitized calcium-contraction coupling.
Paradoxically, in Pkd2þ/ mice, PKA phosphorylation of phospholamban
was decreased, whereas PKA phosphorylation of troponin I was increased, ex-
plaining the decoupling between calcium signaling and contractility. In silico
modeling supported this relationship. Echocardiography measurements showed
that Pkd2þ/ mice have increased left ventricular ejection fraction after stim-
ulation with isoproterenol (ISO), a b-adrenergic receptor (bAR) agonist.
Blockers of bAR-1 and 2 inhibited the ISO response in Pkd2þ/ mice, sug-
gesting that the dephosphorylated state of phospholamban is primarily by
bAR-2 signaling. Importantly, the Pkd2þ/ mice were normotensive and
had no evidence of renal cysts. Our results showed that decreased PC2 levels
shifted the bAR pathway balance and changed expression of calcium handling
proteins, which resulted in altered cardiac contractility. We propose that PC2
levels in the heart directly contribute to cardiac remodeling in ADPKD patients
in the absence of renal dysfunction.
894-Plat
In vivo Reconstitution of the Mitochondrial Uniporter
Erika Kovacs-Bogdan1, Yasemin Sancak1, Kimberli J. Kamer1,
Molly Plovanich1, Ashwini Jambhekar1, Robert J. Huber2, Michael A. Myre2,
Michael D. Blower1, Vamsi K. Mootha1.
1Molecular Biology, Massachusetts General Hospital, Boston, MA, USA,
2Department of Neurology, Massachusetts General Hospital, Boston,
MA, USA.
The mitochondrial uniporter is a highly selective calcium channel present
broadly in eukaryotes, but absent in Saccharomyces cerevisiae. Therefore,
178a Monday, February 9, 2015we used yeast as a reconstitution system to identify the minimal components
sufficient for in vivo uniporter activity. First, we considered Dictyostelium dis-
coideum and showed that it has a highly simplified uniporter machinery: the
expression of DdMCU, a single transmembrane component alone is sufficient
to reconstitute mitochondrial calcium uniporter activity. Second, to establish
human uniporter activity, the coexpression of MCU and - the animal specific
protein - EMRE is necessary, whereas expression of MCU alone is insufficient.
Our work established yeast as a powerful in vivo reconstitution system for the
uniporter to study the evolution and function of this channel.
895-Plat
Fluctuations in Calcium Concentration Alter the Temporal Dynamics of
Calcium-Dependent Signaling Cascades
Seth H. Weinberg.
Virginia Modeling, Analysis and Simulation Center, Old Dominion
University, Chesapeake, VA, USA.
Calcium signaling is often localized in spatially restricted ‘‘microdomains,’’
which may involve only 1-100 calcium ions. Fluctuations in the local calcium
concentration can arise from calcium influx and association/dissociation with
calcium buffers [Weinberg and Smith. Biophys J 106(12): 2693 (2014)]. How-
ever it is unclear to what extent these fluctuations alter calcium-dependent
signaling cascades. We construct a Markov model of a calcium-dependent
signaling cascade and compare the first hitting time distribution for a Markov
model that accounts for calcium fluctuations, a phase-type distribution that can
be calculated from the infinitesimal generator matrix, with the corresponding
model that neglects these fluctuations. In general, when calcium fluctuations
are much faster than the characteristic time for the signaling cascade, the dis-
tributions for the two processes are similar. However, when the time scale of
calcium fluctuations is on the same order as the signaling cascade or slower,
the mean and variance of the hitting time is increased, in particular when the
number of calcium ions is small, a consequence of a long-tailed hitting time dis-
tribution. These ‘‘rare events’’ comprising the long tail can be significant and
have a physiological impact. We further study calcium fluctuations in two set-
tings: calcium-dependent synaptic vesicle release [Bollmann et al. Science 289,
953 (2000)] and a calcium-release site model composed of calcium-activated
calcium channels [DeRemigio and Smith. Cell Calcium 38: 73 (2005)]. In these
models, we demonstrate the conditions for which calcium fluctuations alter the
distribution, mean, and variance of the timing for synaptic vesicle release and
calcium-release site activation, respectively. Under physiological conditions,
the mean hitting time can be increased orders of magnitude when calcium fluc-
tuations are accounted for, demonstrating a significant influence on intracel-
lular signaling.
896-Plat
Visualizing Calcium Influx through Single Orai1 Channels
Joseph Dynes, Anna Amcheslavsky, Michael Cahalan.
Physiology and Biophysics, UC Irvine, Irvine, CA, USA.
Orai is the pore-forming subunit of two-component channels that mediate store-
operated calcium entry (SOCE). When activated by the ER resident calcium
sensor STIM, Orai channels possess high selectivity for calcium but an
extremely small conductance (~10 fS in 2 mM Ca2þ from noise analysis)
that has precluded direct recording of single channel currents. We have devel-
oped an approach to visualize the activity of single Orai1 channels by fusing
human Orai1 to a fluorescent, genetically-encoded calcium indicator (GECI).
Whole-cell recording in HEK 293 cells co-transfected with STIM1 showed
that GECI-Orai1 is fully functional as a CRAC channel, with normal activation
rates, current amplitudes, ion selectivity and rectification, and Ca2þ-dependent
inactivation. When GECI-Orai1 and the CRAC-activating domain (CAD) of
STIM1 were co-expressed at low levels and imaged using a TIRF microscope,
cells exhibited sporadic fluorescence transients the size of diffraction-limited
spots and the brightness of a few activated GECI proteins. Transients typically
rose to a maximum within 100-200 milliseconds and fell into two classes
according to duration: briefer ‘‘flickers’’ lasting only a few hundred millisec-
onds, and longer ‘‘pulses’’ lasting ~1 to several seconds. The frequency of
both classes increased as CAD expression levels were increased. GECI-Orai1
transients exhibited physiological characteristics expected for single Orai1
channels in the plasma membrane, including rapid response to changes in extra-
cellular calcium, enhancement by valinomycin-induced hyperpolarization, and
block by trivalent cations. When single molecule GECI-Orai1 traces were
aligned by the rise in green fluorescence, a corresponding rise in mCherry-
CAD fluorescence, indicative of binding, was observed. These data indicate
that GECI-Orai1 transients correspond to the opening of single Ora1 channels
gated by CAD. These first recordings of single channel Orai1 currents reveal
unexpected dynamics, and when paired with CAD association, support multiple
single channel states.897-Plat
Functional Reconstitution and Structural Flexibility of the CRACChannel
Orai
Xiaowei Hou, Stephen B. Long.
MSKCC, New York, NY, USA.
Calcium (Ca2þ) release-activated Ca2þ (CRAC) channels mediate Ca2þ influx
across the plasma membrane in response to Ca2þ store depletion in the endo-
plasmic reticulum (ER). CRAC channel function requires two components:
the plasma membrane Ca2þ channel Orai and its regulator located in the ER
membrane, the Ca2þ store sensor STIM. Using liposomes reconstituted with
a purified fusion protein of human Orai1 and cytosolic fragments of human
STIM1 (hO1-SS), we show that Orai1 and STIM1 are sufficient to form active
CRAC channels in vitro. Reconstituted hO1-SS recapitulates CRAC channel
properties as shown by detection of sodium (Naþ) flux in the absence of
Ca2þ and by direct detection of Ca2þ flux. 2-APB, a known CRAC channel in-
hibitor, blocks both fluxes. Our findings confirm that human STIM1 gates the
pore of Orai1 and demonstrates that the two proteins are sufficient to form func-
tional channels in the absence of other cellular factors. Previously, we pub-
lished the crystal structure of drosophila Orai in a closed state. Here we
present low-resolution X-ray diffraction data of human Orai1, which indicate
an overall structure that is indistinguishable from drosophila Orai. In addition,
a new 4.25 A˚ resolution X-ray structure of drosophila Orai reveals an extended
conformation of the fourth transmembrane helix (M4) at the periphery of the
channel that extends into the cytosol and is strikingly different from the
arrangement of these helices in the previous structure. The comparison of struc-
tures reveals conformational flexibility that starts from the M4 helices and con-
tinues into the cytosolic M4 extension helices. In all of the structures, the pore
adopts the same conformation and remains closed. The conformational flexi-
bility observed for the M4 and M4 extension helices may have a role in the
binding of STIM and in signal transduction from the ER.
898-Plat
Thermodynamic and Structural Analysis of Calmodulin Interaction with
the Skeletal Muscle Ryanodine Receptor
Adina M. Kilpatrick1, Liam Hovey2, Madeline A. Shea2.
1Department of Physics and Astronomy, Drake University, Des Moines, IA,
USA, 2Department of Biochemistry, University of Iowa Carver College of
Medicine, Iowa City, IA, USA.
In skeletal muscle, the calcium sensor calmodulin (CaM) plays a key role in
excitation-contraction coupling, the process of translating neuronal stimuli
into mechanical contraction of muscle, by regulating the opening and closing
of the calcium channel ryanodine receptor (RyR1). By interacting with this
channel differently at high and low calcium, CaM acts as a feedback regulator
of calcium levels during muscle contraction: at low calcium, CaM weakly
activates RyR1, while calcium-CaM inhibits it. We are investigating the inter-
action between CaM and its established binding site on RyR1 (CaMBD, resi-
dues 3614-3640) using a multi-faceted approach combining biophysical
(fluorescence spectroscopy) and structural (solution NMR) methodologies.
Fo¨rster resonance energy transfer (FRET) experiments in an auto-fluorescent
biosensor construct (YFP-CaMBD-CFP) enabled us to determine Gibbs free
energies of binding in the absence and the presence of calcium. Using this sys-
tem, we systematically explored the thermodynamics of molecular recognition
between the two biomolecules in high and low calcium environments, as well
as the roles played by individual RyR1 residues and each CaM lobe at the
interface. To gain additional insights into the interplay between the processes
of calcium- and target-binding to CaM, we analyzed the interaction between
wild-type or mutated RyR1 CaMBD sequences and CaM mutants in which
the calcium-binding sites in one domain had been rendered non-functional.
Overall, these experiments show that CaM C-domain binding to molecular
determinants in the N-terminus of RyR1 CAMBD dominates the interaction,
both in the presence and the absence of calcium. However, the interaction is
three orders of magnitude stronger at high calcium levels. To obtain
residue-specific information of the binding interface, we are currently under-
taking NMR studies of isotopically labeled CaM (wild-type and calcium-
binding mutants) in the absence and presence of wild-type and mutated
RyR1 sequences.
899-Plat
Stretch-Induced Changes in Atrial Ca Signaling
Maura Greiser, Chris Ward, W. Jonathan Lederer.
University of Maryland, Baltimore, MD, USA.
Atrial myocytes undergo stretch during diastole as do ventricular myocytes.
We have identified a novel mechanism that links cellular stretch in ventricular
myocytes to the tuning of Ca2þ release from the sarcoplasmic reticulum
(SR)(Prosser et al. Science 2011;333:1440-5). This mechanism, ‘‘X-ROS
